Evidence map›Paper›PMID 37807413›Full record

ReviewCurrent medicinal chemistry2024

The Mechanisms of miRNAs on Target Regulation and their Recent Advances in Atherosclerosis.

Runting Yin, Hongyu Lu, Yixin Cao, Jia Zhang, Geng Liu, Qian Guo, Xinyu Kai, Jiemin Zhao, Yuan Wei

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Runting YinSchool of Pharmacy, Jiangsu University, No. 301, Xuefu Road, Zhenjiang, 212000, China.
Hongyu LuSchool of Pharmacy, Jiangsu University, No. 301, Xuefu Road, Zhenjiang, 212000, China.
Yixin CaoDepartment of Medical Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Jia ZhangSchool of Pharmacy, Jiangsu University, No. 301, Xuefu Road, Zhenjiang, 212000, China.
Geng LiuSchool of Pharmacy, Jiangsu University, No. 301, Xuefu Road, Zhenjiang, 212000, China.
Qian GuoSchool of Pharmacy, Jiangsu University, No. 301, Xuefu Road, Zhenjiang, 212000, China.
Xinyu KaiSchool of Pharmacy, Jiangsu University, No. 301, Xuefu Road, Zhenjiang, 212000, China.
Jiemin ZhaoSchool of Pharmacy, Jiangsu University, No. 301, Xuefu Road, Zhenjiang, 212000, China.
Yuan WeiSchool of Pharmacy, Jiangsu University, No. 301, Xuefu Road, Zhenjiang, 212000, China.
Jiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miRNAs are crucial regulators in a variety of physiological and pathological processes, while their regulation mechanisms were usually described as negatively regulating gene expression by targeting the 3'-untranslated region(3'-UTR) of target gene miRNAs through seed sequence in tremendous studies. However, recent evidence indicated the existence of non-canonical mechanisms mediated by binding other molecules besides mRNAs. Additionally, accumulating evidence showed that functions of intracellular and intercellular miRNAs exhibited spatiotemporal patterns. Considering that detailed knowledge of the miRNA regulating mechanism is essential for understanding the roles and further clinical applications associated with their dysfunction and dysregulation, which is complicated and not fully clarified. Based on that, we summarized the recently reported regulation mechanisms of miRNAs, including recognitions, patterns of actions, and chemical modifications. And we also highlight the novel findings of miRNAs in atherosclerosis progression researches to provide new insights for non-coding RNA-based therapy in intractable diseases.

Indexed as

AtherosclerosisMicroRNAs3' Untranslated RegionsAnimalsGene Expression RegulationHumans3' Untranslated RegionsMicroRNAsargonauteatherosclerosismethylation modificationmiRNA spongemiRNA targetpri-miRNAs.

Identifiers

PMID37807413
OpenAlexW4387440984

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.